Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

The Coal Tar Market will register a CAGR of close to 2% by 2023

Posted on: 03 Jan 19
The Coal Tar Market will register a CAGR of close to 2% by 2023

PR Newswire

LONDON, Jan. 3, 2019

LONDON, Jan. 3, 2019 /PRNewswire/ -- About this market
Application of coal tar in roofing to gain traction in the market. Coal tar is favored because of its durability. A coal tar BUR system is also ideal for roofs where it is prone to getting wet constantly. Technavio's analysts have predicted that the coal tar market will register a CAGR of close to 2% by 2023.

Download the full report:

Market Overview
Demand for coal tar products from the healthcare sector
Coal tar has various applications in the healthcare industry. Coal tar is a topical medicine and has been used to treat many skin diseases, such as psoriasis, seborrheic dermatitis, eczema, and dandruff.
Use of alternative chemicals
Coal tar is also being replaced in roofing applications with thermoplastic olefin (TPO) due to TPO's high durability and ability to withstand wear and tear and other environmental impacts.
For the detailed list of factors that will drive and challenge the growth of the coal tar market during the 2019-2023, view our report.

Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Tata Steel and voestalpine the competitive environment is quite intense. Factors such as the demand for coal tar products from the healthcare sector and the application of coal tar in roofing, will provide considerable growth opportunities to coal tar manufactures. ArcelorMittal, POSCO, Sumitomo, Tata Steel, and voestalpine are some of the major companies covered in this report.

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +1 (718) 213 4904

View original content:

SOURCE ReportBuyer

PR Newswire

Last updated on: 03/01/2019

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.